CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 192 filers reported holding CYTOKINETICS INC in Q2 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,847,692 | +104.9% | 96,663 | +126.9% | 0.01% | +166.7% |
| Q2 2023 | $1,389,612 | -81.6% | 42,600 | -80.2% | 0.00% | -86.4% |
| Q1 2023 | $7,568,771 | -5.9% | 215,083 | +22.6% | 0.02% | -12.0% |
| Q4 2022 | $8,039,623 | +635.6% | 175,461 | +678.1% | 0.02% | +525.0% |
| Q3 2022 | $1,093,000 | -66.0% | 22,551 | -74.2% | 0.00% | -55.6% |
| Q1 2022 | $3,214,000 | -88.0% | 87,325 | -85.2% | 0.01% | -84.2% |
| Q4 2021 | $26,835,000 | +10.7% | 588,741 | -13.2% | 0.06% | +5.6% |
| Q3 2021 | $24,252,000 | +198.7% | 678,574 | +65.4% | 0.05% | +200.0% |
| Q2 2021 | $8,119,000 | -36.1% | 410,243 | -24.9% | 0.02% | -45.5% |
| Q1 2021 | $12,705,000 | +404.4% | 546,215 | +350.5% | 0.03% | +371.4% |
| Q4 2020 | $2,519,000 | -82.6% | 121,246 | -81.9% | 0.01% | -86.3% |
| Q3 2020 | $14,464,000 | +39.9% | 668,074 | +52.3% | 0.05% | 0.0% |
| Q2 2020 | $10,342,000 | +135.7% | 438,788 | +17.9% | 0.05% | +41.7% |
| Q1 2020 | $4,387,000 | -10.6% | 372,092 | -19.5% | 0.04% | +140.0% |
| Q4 2019 | $4,907,000 | +260.8% | 462,450 | +287.1% | 0.02% | +200.0% |
| Q3 2019 | $1,360,000 | -54.9% | 119,470 | -55.5% | 0.01% | -50.0% |
| Q2 2019 | $3,017,000 | -3.5% | 268,215 | -30.6% | 0.01% | 0.0% |
| Q1 2019 | $3,126,000 | +993.0% | 386,412 | +754.1% | 0.01% | +900.0% |
| Q4 2018 | $286,000 | -9.5% | 45,242 | +41.0% | 0.00% | 0.0% |
| Q3 2018 | $316,000 | -43.1% | 32,080 | -52.0% | 0.00% | -50.0% |
| Q2 2018 | $555,000 | +25.0% | 66,848 | +8.4% | 0.00% | +100.0% |
| Q1 2018 | $444,000 | -52.2% | 61,676 | -45.9% | 0.00% | -66.7% |
| Q4 2017 | $928,000 | +101.3% | 113,902 | +258.1% | 0.00% | +50.0% |
| Q3 2017 | $461,000 | -67.7% | 31,809 | -73.0% | 0.00% | -60.0% |
| Q2 2017 | $1,426,000 | -38.8% | 117,892 | -35.0% | 0.01% | -37.5% |
| Q1 2017 | $2,331,000 | +891.9% | 181,418 | +838.8% | 0.01% | +700.0% |
| Q4 2016 | $235,000 | -67.5% | 19,324 | -75.4% | 0.00% | -66.7% |
| Q3 2016 | $723,000 | +1.7% | 78,710 | -21.9% | 0.00% | 0.0% |
| Q1 2016 | $711,000 | -78.8% | 100,824 | -68.5% | 0.00% | -81.2% |
| Q4 2015 | $3,351,000 | +1155.1% | 320,394 | +703.0% | 0.02% | +1500.0% |
| Q3 2015 | $267,000 | +128.2% | 39,900 | +128.7% | 0.00% | 0.0% |
| Q2 2015 | $117,000 | -36.8% | 17,445 | -38.4% | 0.00% | 0.0% |
| Q4 2013 | $185,000 | -33.5% | 28,338 | -22.8% | 0.00% | -50.0% |
| Q3 2013 | $278,000 | – | 36,726 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |